111 (NASDAQ:YI) Director Jian David Sun Sells 70,440 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 70,440 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $0.25, for a total transaction of $17,610.00. Following the transaction, the director directly owned 710,551 shares of the company’s stock, valued at $177,637.75. This trade represents a 9.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Performance

Shares of YI stock opened at $5.47 on Friday. 111, Inc. Sponsored ADR has a one year low of $2.48 and a one year high of $11.17. The company has a 50 day moving average price of $6.29 and a 200 day moving average price of $5.58. The firm has a market capitalization of $48.08 million, a price-to-earnings ratio of -5.47 and a beta of 0.66.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, May 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.